BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

538 related articles for article (PubMed ID: 9663486)

  • 1. Reduced progression of experimental osteoarthritis in vivo by selective inhibition of inducible nitric oxide synthase.
    Pelletier JP; Jovanovic D; Fernandes JC; Manning P; Connor JR; Currie MG; Di Battista JA; Martel-Pelletier J
    Arthritis Rheum; 1998 Jul; 41(7):1275-86. PubMed ID: 9663486
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Selective inhibition of inducible nitric oxide synthase in experimental osteoarthritis is associated with reduction in tissue levels of catabolic factors.
    Pelletier JP; Lascau-Coman V; Jovanovic D; Fernandes JC; Manning P; Connor JR; Currie MG; Martel-Pelletier J
    J Rheumatol; 1999 Sep; 26(9):2002-14. PubMed ID: 10493683
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Selective inhibition of inducible nitric oxide synthase reduces progression of experimental osteoarthritis in vivo: possible link with the reduction in chondrocyte apoptosis and caspase 3 level.
    Pelletier JP; Jovanovic DV; Lascau-Coman V; Fernandes JC; Manning PT; Connor JR; Currie MG; Martel-Pelletier J
    Arthritis Rheum; 2000 Jun; 43(6):1290-9. PubMed ID: 10857787
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The in situ up-regulation of chondrocyte interleukin-1-converting enzyme and interleukin-18 levels in experimental osteoarthritis is mediated by nitric oxide.
    Boileau C; Martel-Pelletier J; Moldovan F; Jouzeau JY; Netter P; Manning PT; Pelletier JP
    Arthritis Rheum; 2002 Oct; 46(10):2637-47. PubMed ID: 12384922
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chondrocyte death in experimental osteoarthritis is mediated by MEK 1/2 and p38 pathways: role of cyclooxygenase-2 and inducible nitric oxide synthase.
    Pelletier JP; Fernandes JC; Jovanovic DV; Reboul P; Martel-Pelletier J
    J Rheumatol; 2001 Nov; 28(11):2509-19. PubMed ID: 11708426
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The therapeutic effects of tenidap in canine experimental osteoarthritis: relationship with biochemical markers.
    Jovanovic D; Caron JP; Martel-Pelletier J; Fernandes JC; Ricketts T; Pelletier JP
    J Rheumatol; 1997 May; 24(5):916-25. PubMed ID: 9150082
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Licofelone (ML-3000), a dual inhibitor of 5-lipoxygenase and cyclooxygenase, reduces the level of cartilage chondrocyte death in vivo in experimental dog osteoarthritis: inhibition of pro-apoptotic factors.
    Boileau C; Martel-Pelletier J; Jouzeau JY; Netter P; Moldovan F; Laufer S; Tries S; Pelletier JP
    J Rheumatol; 2002 Jul; 29(7):1446-53. PubMed ID: 12136904
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effects of tenidap on canine experimental osteoarthritis: II. Study of the expression of collagenase-1 and interleukin 1beta by in situ hybridization.
    Fernandes JC; Martel-Pelletier J; Jovanovic D; Tardif G; DiBattista JA; Lascau-Coman V; Otterness IG; Pelletier JP
    J Rheumatol; 1998 May; 25(5):951-8. PubMed ID: 9598897
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reduction in the structural changes of experimental osteoarthritis by a nitric oxide inhibitor.
    Pelletier J; Jovanovic D; Fernandes JC; Manning P; Connor JR; Currie MG; Martel-Pelletier J
    Osteoarthritis Cartilage; 1999 Jul; 7(4):416-8. PubMed ID: 10419785
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The in vivo effects of intraarticular corticosteroid injections on cartilage lesions, stromelysin, interleukin-1, and oncogene protein synthesis in experimental osteoarthritis.
    Pelletier JP; DiBattista JA; Raynauld JP; Wilhelm S; Martel-Pelletier J
    Lab Invest; 1995 May; 72(5):578-86. PubMed ID: 7745952
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of tenidap on the progression of osteoarthritic lesions in a canine experimental model. Suppression of metalloprotease and interleukin-1 activity.
    Fernandes JC; Caron JP; Martel-Pelletier J; Jovanovic D; Mineau F; Tardif G; Otterness IG; Pelletier JP
    Arthritis Rheum; 1997 Feb; 40(2):284-94. PubMed ID: 9041940
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vivo selective inhibition of mitogen-activated protein kinase kinase 1/2 in rabbit experimental osteoarthritis is associated with a reduction in the development of structural changes.
    Pelletier JP; Fernandes JC; Brunet J; Moldovan F; Schrier D; Flory C; Martel-Pelletier J
    Arthritis Rheum; 2003 Jun; 48(6):1582-93. PubMed ID: 12794826
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Oral treatment with PD-0200347, an alpha2delta ligand, reduces the development of experimental osteoarthritis by inhibiting metalloproteinases and inducible nitric oxide synthase gene expression and synthesis in cartilage chondrocytes.
    Boileau C; Martel-Pelletier J; Brunet J; Tardif G; Schrier D; Flory C; El-Kattan A; Boily M; Pelletier JP
    Arthritis Rheum; 2005 Feb; 52(2):488-500. PubMed ID: 15693013
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Carprofen simultaneously reduces progression of morphological changes in cartilage and subchondral bone in experimental dog osteoarthritis.
    Pelletier JP; Lajeunesse D; Jovanovic DV; Lascau-Coman V; Jolicoeur FC; Hilal G; Fernandes JC; Martel-Pelletier J
    J Rheumatol; 2000 Dec; 27(12):2893-902. PubMed ID: 11128682
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition of inducible nitric oxide synthase results in reductions in wound vascular endothelial growth factor expression, granulation tissue formation, and local perfusion.
    Howdieshell TR; Webb WL; Sathyanarayana ; McNeil PL
    Surgery; 2003 May; 133(5):528-37. PubMed ID: 12773981
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cartilage protection by nitric oxide synthase inhibitors after intraarticular injection of interleukin-1beta in rats.
    Presle N; Cipolletta C; Jouzeau JY; Abid A; Netter P; Terlain B
    Arthritis Rheum; 1999 Oct; 42(10):2094-102. PubMed ID: 10524680
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pioglitazone, a peroxisome proliferator-activated receptor gamma agonist, reduces the progression of experimental osteoarthritis in guinea pigs.
    Kobayashi T; Notoya K; Naito T; Unno S; Nakamura A; Martel-Pelletier J; Pelletier JP
    Arthritis Rheum; 2005 Feb; 52(2):479-87. PubMed ID: 15692987
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The role of cytokines in osteoarthritis pathophysiology.
    Fernandes JC; Martel-Pelletier J; Pelletier JP
    Biorheology; 2002; 39(1-2):237-46. PubMed ID: 12082286
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interleukin-1, tumor necrosis factor alpha, and interleukin-17 synergistically up-regulate nitric oxide and prostaglandin E2 production in explants of human osteoarthritic knee menisci.
    LeGrand A; Fermor B; Fink C; Pisetsky DS; Weinberg JB; Vail TP; Guilak F
    Arthritis Rheum; 2001 Sep; 44(9):2078-83. PubMed ID: 11592370
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Licofelone reduces progression of structural changes in a canine model of osteoarthritis under curative conditions: effect on protease expression and activity.
    Moreau M; Boileau C; Martel-Pelletier J; Brunet J; Laufer S; Pelletier JP
    J Rheumatol; 2006 Jun; 33(6):1176-83. PubMed ID: 16652435
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 27.